<?xml version="1.0" encoding="UTF-8"?>
<p class="p">FIV is the pathogen of the acquired immunodeficiency syndrome (AIDS) in felines. [
 <xref rid="pone.0204042.ref022" ref-type="bibr" class="xref">22</xref>–
 <xref rid="pone.0204042.ref024" ref-type="bibr" class="xref">24</xref>] It exhibits biological properties very similar to HIV, and as such it is considered a useful non-primate model to study HIV infection, and to test anti-HIV vaccine [
 <xref rid="pone.0204042.ref025" ref-type="bibr" class="xref">25</xref>–
 <xref rid="pone.0204042.ref027" ref-type="bibr" class="xref">27</xref>] and drugs. Analogously to HIV, FIV [
 <xref rid="pone.0204042.ref028" ref-type="bibr" class="xref">28</xref>] enters cells thanks to gp36, the envelope glycoprotein [
 <xref rid="pone.0204042.ref029" ref-type="bibr" class="xref">29</xref>–
 <xref rid="pone.0204042.ref031" ref-type="bibr" class="xref">31</xref>] showing the same structural and functional properties of gp41. [
 <xref rid="pone.0204042.ref032" ref-type="bibr" class="xref">32</xref>–
 <xref rid="pone.0204042.ref034" ref-type="bibr" class="xref">34</xref>] C8, including three equally spaced Trp residues in its sequence, elicits antiviral activity preventing the entry of the virus in the host cells. C8 is endowed with strong membrane binding property, and many evidence show that its antiviral action is based on its ability to prevent the interaction of gp36 MPER with the surface of the host cell. [
 <xref rid="pone.0204042.ref035" ref-type="bibr" class="xref">35</xref>]
</p>
